08/01/2008
Ramin Ebrahimi, MD; Jahandar Saleh, MD; Edward Toggart, MD; Shahdad Azmoon, MD; Hormoz Babaei, MD; Ryan Smith, MD; Stanley A. Rubin, MD; James S. Lee, MD, DO; Atman P. Shah, MD, FACC, FSCAI; Mohammad Reza Movahed, MD, PhD, FACP, FACC, FSCAI
Multiple primary and secondary prevention trials demonstrate a significant reduction in adverse cardiovascular outcomes in patients with, or at risk of, coronary artery disease as a result of statin therapy.1–6 Furthermore, there is...
Multiple primary and secondary prevention trials demonstrate a significant reduction in adverse cardiovascular outcomes in patients with, or at risk of, coronary artery disease as a result of statin therapy.1–6 Furthermore, there is...
Multiple primary and secondary...